Related Experiment Video
Updated: Aug 15, 2026

10:48
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
Published on: December 28, 2017
[New criteria for positron emission tomographic diagnosis of brain glioma using 11C-methionine]
Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko
|September 18, 2001
Abstract:
The study was based on the data of positron emission tomography (PET) and L-[methyl]-[11C]-methionine used in 117 patients with suspected brain tumor. PET data on 74 patients with histologically verified cerebral tumors were analyzed in detail. New additional criteria for assessing PET scans, which formed the PET syndromes of astrocytomas, anaplastic astrocytomas, and glioblastomas. Operative and histological verification confirmed the high validity of the proposed criteria for defining the type of a tumor.
Related Concept Videos
Positron Emission Tomography
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
![Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58641.jpg&w=3840&q=50)
